Overexpression of PCNA in prostate cancer [3, 4] and non-small cell lung carcinoma (NSCLC) [5] is associated with advanced disease and metastasis, and is a reliable biomarker predicting poor prognosis of cancers of various tissue types [3, 4, 6–8]. Here, PCNA is linked to prostate cancer.